Am­gen, Janssen reach set­tle­ment on Ste­lara biosim­i­lar drug, al­low­ing for 2025 launch at lat­est

Am­gen and Janssen set­tled their law­suit over a biosim­i­lar op­tion to J&J’s block­buster bi­o­log­ic Ste­lara — paving the way for the new­er drug to en­ter the mar­ket.

Am­gen told End­points News in a state­ment that the terms of the set­tle­ment, which were an­nounced Mon­day via a court fil­ing, re­main con­fi­den­tial. How­ev­er, Am­gen will be al­lowed to launch its Ste­lara biosim­i­lar “no lat­er than Jan­u­ary 1st, 2025.”

To read Endpoints News become a free subscriber

Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters

SIGN UP LOG IN